SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $120,000 | -98.9% | 10,000 | -98.8% | 0.00% | -98.7% |
| Q1 2021 | $10,756,000 | +6794.9% | 858,429 | +8484.3% | 0.24% | +5825.0% |
| Q4 2020 | $156,000 | +66.0% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $94,000 | +4.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $90,000 | +40.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $64,000 | -23.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $84,000 | -7.7% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $91,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $108,000 | +13.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $95,000 | -17.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $115,000 | -32.0% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $169,000 | +19.0% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $142,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |